0
Politics
Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs
April 27, 2026
Scroll
Posted 2 hours ago by
Novartis, Amgen and Eli Lilly are betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology.
CNBC
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.